Global Chronic Pain Topical Analgesics Supply, Demand and Key Producers, 2023-2029
This report studies the global Chronic Pain Topical Analgesics demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Chronic Pain Topical Analgesics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Chronic Pain Topical Analgesics that contribute to its increasing demand across many markets.
The global Chronic Pain Topical Analgesics market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Highlights and key features of the study
Global Chronic Pain Topical Analgesics total market, 2018-2029, (USD Million)
Global Chronic Pain Topical Analgesics total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Chronic Pain Topical Analgesics total market, key domestic companies and share, (USD Million)
Global Chronic Pain Topical Analgesics revenue by player and market share 2018-2023, (USD Million)
Global Chronic Pain Topical Analgesics total market by Type, CAGR, 2018-2029, (USD Million)
Global Chronic Pain Topical Analgesics total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Chronic Pain Topical Analgesics market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche (Genentech), Amgen, B-MS, Merck, Pfizer, Novartis, Eli Lilly and Company, Johnson & Johnson and GSK, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Chronic Pain Topical Analgesics market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Chronic Pain Topical Analgesics Market, By Region:
1. How big is the global Chronic Pain Topical Analgesics market?
2. What is the demand of the global Chronic Pain Topical Analgesics market?
3. What is the year over year growth of the global Chronic Pain Topical Analgesics market?
4. What is the total value of the global Chronic Pain Topical Analgesics market?
5. Who are the major players in the global Chronic Pain Topical Analgesics market?
6. What are the growth factors driving the market demand?
This report is a detailed and comprehensive analysis of the world market for Chronic Pain Topical Analgesics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Chronic Pain Topical Analgesics that contribute to its increasing demand across many markets.
The global Chronic Pain Topical Analgesics market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Highlights and key features of the study
Global Chronic Pain Topical Analgesics total market, 2018-2029, (USD Million)
Global Chronic Pain Topical Analgesics total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Chronic Pain Topical Analgesics total market, key domestic companies and share, (USD Million)
Global Chronic Pain Topical Analgesics revenue by player and market share 2018-2023, (USD Million)
Global Chronic Pain Topical Analgesics total market by Type, CAGR, 2018-2029, (USD Million)
Global Chronic Pain Topical Analgesics total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Chronic Pain Topical Analgesics market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche (Genentech), Amgen, B-MS, Merck, Pfizer, Novartis, Eli Lilly and Company, Johnson & Johnson and GSK, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Chronic Pain Topical Analgesics market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Chronic Pain Topical Analgesics Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Analgesic Creams
- Analgesic Sprays
- Pain Relief Patches
- Muscle Pain
- Arthritis Pain
- Roche (Genentech)
- Amgen
- B-MS
- Merck
- Pfizer
- Novartis
- Eli Lilly and Company
- Johnson & Johnson
- GSK
- Sanofi
- Boehringer Ingelheim
- Zhejiang Jiuzhou Pharmaceutical
- Hisamitsu
- Mylan
- Lingrui
- Teikoku Seiyaku
- The Pure Source
- Mercury Healthcare
1. How big is the global Chronic Pain Topical Analgesics market?
2. What is the demand of the global Chronic Pain Topical Analgesics market?
3. What is the year over year growth of the global Chronic Pain Topical Analgesics market?
4. What is the total value of the global Chronic Pain Topical Analgesics market?
5. Who are the major players in the global Chronic Pain Topical Analgesics market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Chronic Pain Topical Analgesics Introduction
1.2 World Chronic Pain Topical Analgesics Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Chronic Pain Topical Analgesics Total Market by Region (by Headquarter Location)
1.3.1 World Chronic Pain Topical Analgesics Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Chronic Pain Topical Analgesics Market Size (2018-2029)
1.3.3 China Chronic Pain Topical Analgesics Market Size (2018-2029)
1.3.4 Europe Chronic Pain Topical Analgesics Market Size (2018-2029)
1.3.5 Japan Chronic Pain Topical Analgesics Market Size (2018-2029)
1.3.6 South Korea Chronic Pain Topical Analgesics Market Size (2018-2029)
1.3.7 ASEAN Chronic Pain Topical Analgesics Market Size (2018-2029)
1.3.8 India Chronic Pain Topical Analgesics Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Chronic Pain Topical Analgesics Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Chronic Pain Topical Analgesics Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Chronic Pain Topical Analgesics Consumption Value (2018-2029)
2.2 World Chronic Pain Topical Analgesics Consumption Value by Region
2.2.1 World Chronic Pain Topical Analgesics Consumption Value by Region (2018-2023)
2.2.2 World Chronic Pain Topical Analgesics Consumption Value Forecast by Region (2024-2029)
2.3 United States Chronic Pain Topical Analgesics Consumption Value (2018-2029)
2.4 China Chronic Pain Topical Analgesics Consumption Value (2018-2029)
2.5 Europe Chronic Pain Topical Analgesics Consumption Value (2018-2029)
2.6 Japan Chronic Pain Topical Analgesics Consumption Value (2018-2029)
2.7 South Korea Chronic Pain Topical Analgesics Consumption Value (2018-2029)
2.8 ASEAN Chronic Pain Topical Analgesics Consumption Value (2018-2029)
2.9 India Chronic Pain Topical Analgesics Consumption Value (2018-2029)
3 WORLD CHRONIC PAIN TOPICAL ANALGESICS COMPANIES COMPETITIVE ANALYSIS
3.1 World Chronic Pain Topical Analgesics Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Chronic Pain Topical Analgesics Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Chronic Pain Topical Analgesics in 2022
3.2.3 Global Concentration Ratios (CR8) for Chronic Pain Topical Analgesics in 2022
3.3 Chronic Pain Topical Analgesics Company Evaluation Quadrant
3.4 Chronic Pain Topical Analgesics Market: Overall Company Footprint Analysis
3.4.1 Chronic Pain Topical Analgesics Market: Region Footprint
3.4.2 Chronic Pain Topical Analgesics Market: Company Product Type Footprint
3.4.3 Chronic Pain Topical Analgesics Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Chronic Pain Topical Analgesics Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Chronic Pain Topical Analgesics Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Chronic Pain Topical Analgesics Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Chronic Pain Topical Analgesics Consumption Value Comparison
4.2.1 United States VS China: Chronic Pain Topical Analgesics Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Chronic Pain Topical Analgesics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Chronic Pain Topical Analgesics Companies and Market Share, 2018-2023
4.3.1 United States Based Chronic Pain Topical Analgesics Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Chronic Pain Topical Analgesics Revenue, (2018-2023)
4.4 China Based Companies Chronic Pain Topical Analgesics Revenue and Market Share, 2018-2023
4.4.1 China Based Chronic Pain Topical Analgesics Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Chronic Pain Topical Analgesics Revenue, (2018-2023)
4.5 Rest of World Based Chronic Pain Topical Analgesics Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Chronic Pain Topical Analgesics Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Chronic Pain Topical Analgesics Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Chronic Pain Topical Analgesics Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Analgesic Creams
5.2.2 Analgesic Sprays
5.2.3 Pain Relief Patches
5.3 Market Segment by Type
5.3.1 World Chronic Pain Topical Analgesics Market Size by Type (2018-2023)
5.3.2 World Chronic Pain Topical Analgesics Market Size by Type (2024-2029)
5.3.3 World Chronic Pain Topical Analgesics Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Chronic Pain Topical Analgesics Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Muscle Pain
6.2.2 Arthritis Pain
6.3 Market Segment by Application
6.3.1 World Chronic Pain Topical Analgesics Market Size by Application (2018-2023)
6.3.2 World Chronic Pain Topical Analgesics Market Size by Application (2024-2029)
6.3.3 World Chronic Pain Topical Analgesics Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Roche (Genentech)
7.1.1 Roche (Genentech) Details
7.1.2 Roche (Genentech) Major Business
7.1.3 Roche (Genentech) Chronic Pain Topical Analgesics Product and Services
7.1.4 Roche (Genentech) Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Roche (Genentech) Recent Developments/Updates
7.1.6 Roche (Genentech) Competitive Strengths & Weaknesses
7.2 Amgen
7.2.1 Amgen Details
7.2.2 Amgen Major Business
7.2.3 Amgen Chronic Pain Topical Analgesics Product and Services
7.2.4 Amgen Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Amgen Recent Developments/Updates
7.2.6 Amgen Competitive Strengths & Weaknesses
7.3 B-MS
7.3.1 B-MS Details
7.3.2 B-MS Major Business
7.3.3 B-MS Chronic Pain Topical Analgesics Product and Services
7.3.4 B-MS Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 B-MS Recent Developments/Updates
7.3.6 B-MS Competitive Strengths & Weaknesses
7.4 Merck
7.4.1 Merck Details
7.4.2 Merck Major Business
7.4.3 Merck Chronic Pain Topical Analgesics Product and Services
7.4.4 Merck Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Merck Recent Developments/Updates
7.4.6 Merck Competitive Strengths & Weaknesses
7.5 Pfizer
7.5.1 Pfizer Details
7.5.2 Pfizer Major Business
7.5.3 Pfizer Chronic Pain Topical Analgesics Product and Services
7.5.4 Pfizer Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Pfizer Recent Developments/Updates
7.5.6 Pfizer Competitive Strengths & Weaknesses
7.6 Novartis
7.6.1 Novartis Details
7.6.2 Novartis Major Business
7.6.3 Novartis Chronic Pain Topical Analgesics Product and Services
7.6.4 Novartis Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Novartis Recent Developments/Updates
7.6.6 Novartis Competitive Strengths & Weaknesses
7.7 Eli Lilly and Company
7.7.1 Eli Lilly and Company Details
7.7.2 Eli Lilly and Company Major Business
7.7.3 Eli Lilly and Company Chronic Pain Topical Analgesics Product and Services
7.7.4 Eli Lilly and Company Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Eli Lilly and Company Recent Developments/Updates
7.7.6 Eli Lilly and Company Competitive Strengths & Weaknesses
7.8 Johnson & Johnson
7.8.1 Johnson & Johnson Details
7.8.2 Johnson & Johnson Major Business
7.8.3 Johnson & Johnson Chronic Pain Topical Analgesics Product and Services
7.8.4 Johnson & Johnson Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Johnson & Johnson Recent Developments/Updates
7.8.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.9 GSK
7.9.1 GSK Details
7.9.2 GSK Major Business
7.9.3 GSK Chronic Pain Topical Analgesics Product and Services
7.9.4 GSK Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 GSK Recent Developments/Updates
7.9.6 GSK Competitive Strengths & Weaknesses
7.10 Sanofi
7.10.1 Sanofi Details
7.10.2 Sanofi Major Business
7.10.3 Sanofi Chronic Pain Topical Analgesics Product and Services
7.10.4 Sanofi Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Sanofi Recent Developments/Updates
7.10.6 Sanofi Competitive Strengths & Weaknesses
7.11 Boehringer Ingelheim
7.11.1 Boehringer Ingelheim Details
7.11.2 Boehringer Ingelheim Major Business
7.11.3 Boehringer Ingelheim Chronic Pain Topical Analgesics Product and Services
7.11.4 Boehringer Ingelheim Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Boehringer Ingelheim Recent Developments/Updates
7.11.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.12 Zhejiang Jiuzhou Pharmaceutical
7.12.1 Zhejiang Jiuzhou Pharmaceutical Details
7.12.2 Zhejiang Jiuzhou Pharmaceutical Major Business
7.12.3 Zhejiang Jiuzhou Pharmaceutical Chronic Pain Topical Analgesics Product and Services
7.12.4 Zhejiang Jiuzhou Pharmaceutical Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Zhejiang Jiuzhou Pharmaceutical Recent Developments/Updates
7.12.6 Zhejiang Jiuzhou Pharmaceutical Competitive Strengths & Weaknesses
7.13 Hisamitsu
7.13.1 Hisamitsu Details
7.13.2 Hisamitsu Major Business
7.13.3 Hisamitsu Chronic Pain Topical Analgesics Product and Services
7.13.4 Hisamitsu Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Hisamitsu Recent Developments/Updates
7.13.6 Hisamitsu Competitive Strengths & Weaknesses
7.14 Mylan
7.14.1 Mylan Details
7.14.2 Mylan Major Business
7.14.3 Mylan Chronic Pain Topical Analgesics Product and Services
7.14.4 Mylan Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Mylan Recent Developments/Updates
7.14.6 Mylan Competitive Strengths & Weaknesses
7.15 Lingrui
7.15.1 Lingrui Details
7.15.2 Lingrui Major Business
7.15.3 Lingrui Chronic Pain Topical Analgesics Product and Services
7.15.4 Lingrui Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Lingrui Recent Developments/Updates
7.15.6 Lingrui Competitive Strengths & Weaknesses
7.16 Teikoku Seiyaku
7.16.1 Teikoku Seiyaku Details
7.16.2 Teikoku Seiyaku Major Business
7.16.3 Teikoku Seiyaku Chronic Pain Topical Analgesics Product and Services
7.16.4 Teikoku Seiyaku Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Teikoku Seiyaku Recent Developments/Updates
7.16.6 Teikoku Seiyaku Competitive Strengths & Weaknesses
7.17 The Pure Source
7.17.1 The Pure Source Details
7.17.2 The Pure Source Major Business
7.17.3 The Pure Source Chronic Pain Topical Analgesics Product and Services
7.17.4 The Pure Source Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 The Pure Source Recent Developments/Updates
7.17.6 The Pure Source Competitive Strengths & Weaknesses
7.18 Mercury Healthcare
7.18.1 Mercury Healthcare Details
7.18.2 Mercury Healthcare Major Business
7.18.3 Mercury Healthcare Chronic Pain Topical Analgesics Product and Services
7.18.4 Mercury Healthcare Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Mercury Healthcare Recent Developments/Updates
7.18.6 Mercury Healthcare Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Chronic Pain Topical Analgesics Industry Chain
8.2 Chronic Pain Topical Analgesics Upstream Analysis
8.3 Chronic Pain Topical Analgesics Midstream Analysis
8.4 Chronic Pain Topical Analgesics Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Chronic Pain Topical Analgesics Introduction
1.2 World Chronic Pain Topical Analgesics Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Chronic Pain Topical Analgesics Total Market by Region (by Headquarter Location)
1.3.1 World Chronic Pain Topical Analgesics Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Chronic Pain Topical Analgesics Market Size (2018-2029)
1.3.3 China Chronic Pain Topical Analgesics Market Size (2018-2029)
1.3.4 Europe Chronic Pain Topical Analgesics Market Size (2018-2029)
1.3.5 Japan Chronic Pain Topical Analgesics Market Size (2018-2029)
1.3.6 South Korea Chronic Pain Topical Analgesics Market Size (2018-2029)
1.3.7 ASEAN Chronic Pain Topical Analgesics Market Size (2018-2029)
1.3.8 India Chronic Pain Topical Analgesics Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Chronic Pain Topical Analgesics Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Chronic Pain Topical Analgesics Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Chronic Pain Topical Analgesics Consumption Value (2018-2029)
2.2 World Chronic Pain Topical Analgesics Consumption Value by Region
2.2.1 World Chronic Pain Topical Analgesics Consumption Value by Region (2018-2023)
2.2.2 World Chronic Pain Topical Analgesics Consumption Value Forecast by Region (2024-2029)
2.3 United States Chronic Pain Topical Analgesics Consumption Value (2018-2029)
2.4 China Chronic Pain Topical Analgesics Consumption Value (2018-2029)
2.5 Europe Chronic Pain Topical Analgesics Consumption Value (2018-2029)
2.6 Japan Chronic Pain Topical Analgesics Consumption Value (2018-2029)
2.7 South Korea Chronic Pain Topical Analgesics Consumption Value (2018-2029)
2.8 ASEAN Chronic Pain Topical Analgesics Consumption Value (2018-2029)
2.9 India Chronic Pain Topical Analgesics Consumption Value (2018-2029)
3 WORLD CHRONIC PAIN TOPICAL ANALGESICS COMPANIES COMPETITIVE ANALYSIS
3.1 World Chronic Pain Topical Analgesics Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Chronic Pain Topical Analgesics Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Chronic Pain Topical Analgesics in 2022
3.2.3 Global Concentration Ratios (CR8) for Chronic Pain Topical Analgesics in 2022
3.3 Chronic Pain Topical Analgesics Company Evaluation Quadrant
3.4 Chronic Pain Topical Analgesics Market: Overall Company Footprint Analysis
3.4.1 Chronic Pain Topical Analgesics Market: Region Footprint
3.4.2 Chronic Pain Topical Analgesics Market: Company Product Type Footprint
3.4.3 Chronic Pain Topical Analgesics Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Chronic Pain Topical Analgesics Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Chronic Pain Topical Analgesics Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Chronic Pain Topical Analgesics Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Chronic Pain Topical Analgesics Consumption Value Comparison
4.2.1 United States VS China: Chronic Pain Topical Analgesics Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Chronic Pain Topical Analgesics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Chronic Pain Topical Analgesics Companies and Market Share, 2018-2023
4.3.1 United States Based Chronic Pain Topical Analgesics Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Chronic Pain Topical Analgesics Revenue, (2018-2023)
4.4 China Based Companies Chronic Pain Topical Analgesics Revenue and Market Share, 2018-2023
4.4.1 China Based Chronic Pain Topical Analgesics Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Chronic Pain Topical Analgesics Revenue, (2018-2023)
4.5 Rest of World Based Chronic Pain Topical Analgesics Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Chronic Pain Topical Analgesics Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Chronic Pain Topical Analgesics Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Chronic Pain Topical Analgesics Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Analgesic Creams
5.2.2 Analgesic Sprays
5.2.3 Pain Relief Patches
5.3 Market Segment by Type
5.3.1 World Chronic Pain Topical Analgesics Market Size by Type (2018-2023)
5.3.2 World Chronic Pain Topical Analgesics Market Size by Type (2024-2029)
5.3.3 World Chronic Pain Topical Analgesics Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Chronic Pain Topical Analgesics Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Muscle Pain
6.2.2 Arthritis Pain
6.3 Market Segment by Application
6.3.1 World Chronic Pain Topical Analgesics Market Size by Application (2018-2023)
6.3.2 World Chronic Pain Topical Analgesics Market Size by Application (2024-2029)
6.3.3 World Chronic Pain Topical Analgesics Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Roche (Genentech)
7.1.1 Roche (Genentech) Details
7.1.2 Roche (Genentech) Major Business
7.1.3 Roche (Genentech) Chronic Pain Topical Analgesics Product and Services
7.1.4 Roche (Genentech) Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Roche (Genentech) Recent Developments/Updates
7.1.6 Roche (Genentech) Competitive Strengths & Weaknesses
7.2 Amgen
7.2.1 Amgen Details
7.2.2 Amgen Major Business
7.2.3 Amgen Chronic Pain Topical Analgesics Product and Services
7.2.4 Amgen Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Amgen Recent Developments/Updates
7.2.6 Amgen Competitive Strengths & Weaknesses
7.3 B-MS
7.3.1 B-MS Details
7.3.2 B-MS Major Business
7.3.3 B-MS Chronic Pain Topical Analgesics Product and Services
7.3.4 B-MS Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 B-MS Recent Developments/Updates
7.3.6 B-MS Competitive Strengths & Weaknesses
7.4 Merck
7.4.1 Merck Details
7.4.2 Merck Major Business
7.4.3 Merck Chronic Pain Topical Analgesics Product and Services
7.4.4 Merck Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Merck Recent Developments/Updates
7.4.6 Merck Competitive Strengths & Weaknesses
7.5 Pfizer
7.5.1 Pfizer Details
7.5.2 Pfizer Major Business
7.5.3 Pfizer Chronic Pain Topical Analgesics Product and Services
7.5.4 Pfizer Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Pfizer Recent Developments/Updates
7.5.6 Pfizer Competitive Strengths & Weaknesses
7.6 Novartis
7.6.1 Novartis Details
7.6.2 Novartis Major Business
7.6.3 Novartis Chronic Pain Topical Analgesics Product and Services
7.6.4 Novartis Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Novartis Recent Developments/Updates
7.6.6 Novartis Competitive Strengths & Weaknesses
7.7 Eli Lilly and Company
7.7.1 Eli Lilly and Company Details
7.7.2 Eli Lilly and Company Major Business
7.7.3 Eli Lilly and Company Chronic Pain Topical Analgesics Product and Services
7.7.4 Eli Lilly and Company Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Eli Lilly and Company Recent Developments/Updates
7.7.6 Eli Lilly and Company Competitive Strengths & Weaknesses
7.8 Johnson & Johnson
7.8.1 Johnson & Johnson Details
7.8.2 Johnson & Johnson Major Business
7.8.3 Johnson & Johnson Chronic Pain Topical Analgesics Product and Services
7.8.4 Johnson & Johnson Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Johnson & Johnson Recent Developments/Updates
7.8.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.9 GSK
7.9.1 GSK Details
7.9.2 GSK Major Business
7.9.3 GSK Chronic Pain Topical Analgesics Product and Services
7.9.4 GSK Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 GSK Recent Developments/Updates
7.9.6 GSK Competitive Strengths & Weaknesses
7.10 Sanofi
7.10.1 Sanofi Details
7.10.2 Sanofi Major Business
7.10.3 Sanofi Chronic Pain Topical Analgesics Product and Services
7.10.4 Sanofi Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Sanofi Recent Developments/Updates
7.10.6 Sanofi Competitive Strengths & Weaknesses
7.11 Boehringer Ingelheim
7.11.1 Boehringer Ingelheim Details
7.11.2 Boehringer Ingelheim Major Business
7.11.3 Boehringer Ingelheim Chronic Pain Topical Analgesics Product and Services
7.11.4 Boehringer Ingelheim Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Boehringer Ingelheim Recent Developments/Updates
7.11.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.12 Zhejiang Jiuzhou Pharmaceutical
7.12.1 Zhejiang Jiuzhou Pharmaceutical Details
7.12.2 Zhejiang Jiuzhou Pharmaceutical Major Business
7.12.3 Zhejiang Jiuzhou Pharmaceutical Chronic Pain Topical Analgesics Product and Services
7.12.4 Zhejiang Jiuzhou Pharmaceutical Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Zhejiang Jiuzhou Pharmaceutical Recent Developments/Updates
7.12.6 Zhejiang Jiuzhou Pharmaceutical Competitive Strengths & Weaknesses
7.13 Hisamitsu
7.13.1 Hisamitsu Details
7.13.2 Hisamitsu Major Business
7.13.3 Hisamitsu Chronic Pain Topical Analgesics Product and Services
7.13.4 Hisamitsu Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Hisamitsu Recent Developments/Updates
7.13.6 Hisamitsu Competitive Strengths & Weaknesses
7.14 Mylan
7.14.1 Mylan Details
7.14.2 Mylan Major Business
7.14.3 Mylan Chronic Pain Topical Analgesics Product and Services
7.14.4 Mylan Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Mylan Recent Developments/Updates
7.14.6 Mylan Competitive Strengths & Weaknesses
7.15 Lingrui
7.15.1 Lingrui Details
7.15.2 Lingrui Major Business
7.15.3 Lingrui Chronic Pain Topical Analgesics Product and Services
7.15.4 Lingrui Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Lingrui Recent Developments/Updates
7.15.6 Lingrui Competitive Strengths & Weaknesses
7.16 Teikoku Seiyaku
7.16.1 Teikoku Seiyaku Details
7.16.2 Teikoku Seiyaku Major Business
7.16.3 Teikoku Seiyaku Chronic Pain Topical Analgesics Product and Services
7.16.4 Teikoku Seiyaku Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Teikoku Seiyaku Recent Developments/Updates
7.16.6 Teikoku Seiyaku Competitive Strengths & Weaknesses
7.17 The Pure Source
7.17.1 The Pure Source Details
7.17.2 The Pure Source Major Business
7.17.3 The Pure Source Chronic Pain Topical Analgesics Product and Services
7.17.4 The Pure Source Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 The Pure Source Recent Developments/Updates
7.17.6 The Pure Source Competitive Strengths & Weaknesses
7.18 Mercury Healthcare
7.18.1 Mercury Healthcare Details
7.18.2 Mercury Healthcare Major Business
7.18.3 Mercury Healthcare Chronic Pain Topical Analgesics Product and Services
7.18.4 Mercury Healthcare Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Mercury Healthcare Recent Developments/Updates
7.18.6 Mercury Healthcare Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Chronic Pain Topical Analgesics Industry Chain
8.2 Chronic Pain Topical Analgesics Upstream Analysis
8.3 Chronic Pain Topical Analgesics Midstream Analysis
8.4 Chronic Pain Topical Analgesics Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Chronic Pain Topical Analgesics Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Chronic Pain Topical Analgesics Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Chronic Pain Topical Analgesics Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Chronic Pain Topical Analgesics Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Chronic Pain Topical Analgesics Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Chronic Pain Topical Analgesics Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Chronic Pain Topical Analgesics Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Chronic Pain Topical Analgesics Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Chronic Pain Topical Analgesics Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Chronic Pain Topical Analgesics Players in 2022
Table 12. World Chronic Pain Topical Analgesics Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Chronic Pain Topical Analgesics Company Evaluation Quadrant
Table 14. Head Office of Key Chronic Pain Topical Analgesics Player
Table 15. Chronic Pain Topical Analgesics Market: Company Product Type Footprint
Table 16. Chronic Pain Topical Analgesics Market: Company Product Application Footprint
Table 17. Chronic Pain Topical Analgesics Mergers & Acquisitions Activity
Table 18. United States VS China Chronic Pain Topical Analgesics Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Chronic Pain Topical Analgesics Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Chronic Pain Topical Analgesics Companies, Headquarters (States, Country)
Table 21. United States Based Companies Chronic Pain Topical Analgesics Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Chronic Pain Topical Analgesics Revenue Market Share (2018-2023)
Table 23. China Based Chronic Pain Topical Analgesics Companies, Headquarters (Province, Country)
Table 24. China Based Companies Chronic Pain Topical Analgesics Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Chronic Pain Topical Analgesics Revenue Market Share (2018-2023)
Table 26. Rest of World Based Chronic Pain Topical Analgesics Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Chronic Pain Topical Analgesics Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Chronic Pain Topical Analgesics Revenue Market Share (2018-2023)
Table 29. World Chronic Pain Topical Analgesics Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Chronic Pain Topical Analgesics Market Size by Type (2018-2023) & (USD Million)
Table 31. World Chronic Pain Topical Analgesics Market Size by Type (2024-2029) & (USD Million)
Table 32. World Chronic Pain Topical Analgesics Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Chronic Pain Topical Analgesics Market Size by Application (2018-2023) & (USD Million)
Table 34. World Chronic Pain Topical Analgesics Market Size by Application (2024-2029) & (USD Million)
Table 35. Roche (Genentech) Basic Information, Area Served and Competitors
Table 36. Roche (Genentech) Major Business
Table 37. Roche (Genentech) Chronic Pain Topical Analgesics Product and Services
Table 38. Roche (Genentech) Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Roche (Genentech) Recent Developments/Updates
Table 40. Roche (Genentech) Competitive Strengths & Weaknesses
Table 41. Amgen Basic Information, Area Served and Competitors
Table 42. Amgen Major Business
Table 43. Amgen Chronic Pain Topical Analgesics Product and Services
Table 44. Amgen Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Amgen Recent Developments/Updates
Table 46. Amgen Competitive Strengths & Weaknesses
Table 47. B-MS Basic Information, Area Served and Competitors
Table 48. B-MS Major Business
Table 49. B-MS Chronic Pain Topical Analgesics Product and Services
Table 50. B-MS Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. B-MS Recent Developments/Updates
Table 52. B-MS Competitive Strengths & Weaknesses
Table 53. Merck Basic Information, Area Served and Competitors
Table 54. Merck Major Business
Table 55. Merck Chronic Pain Topical Analgesics Product and Services
Table 56. Merck Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Merck Recent Developments/Updates
Table 58. Merck Competitive Strengths & Weaknesses
Table 59. Pfizer Basic Information, Area Served and Competitors
Table 60. Pfizer Major Business
Table 61. Pfizer Chronic Pain Topical Analgesics Product and Services
Table 62. Pfizer Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Pfizer Recent Developments/Updates
Table 64. Pfizer Competitive Strengths & Weaknesses
Table 65. Novartis Basic Information, Area Served and Competitors
Table 66. Novartis Major Business
Table 67. Novartis Chronic Pain Topical Analgesics Product and Services
Table 68. Novartis Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Novartis Recent Developments/Updates
Table 70. Novartis Competitive Strengths & Weaknesses
Table 71. Eli Lilly and Company Basic Information, Area Served and Competitors
Table 72. Eli Lilly and Company Major Business
Table 73. Eli Lilly and Company Chronic Pain Topical Analgesics Product and Services
Table 74. Eli Lilly and Company Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Eli Lilly and Company Recent Developments/Updates
Table 76. Eli Lilly and Company Competitive Strengths & Weaknesses
Table 77. Johnson & Johnson Basic Information, Area Served and Competitors
Table 78. Johnson & Johnson Major Business
Table 79. Johnson & Johnson Chronic Pain Topical Analgesics Product and Services
Table 80. Johnson & Johnson Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Johnson & Johnson Recent Developments/Updates
Table 82. Johnson & Johnson Competitive Strengths & Weaknesses
Table 83. GSK Basic Information, Area Served and Competitors
Table 84. GSK Major Business
Table 85. GSK Chronic Pain Topical Analgesics Product and Services
Table 86. GSK Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. GSK Recent Developments/Updates
Table 88. GSK Competitive Strengths & Weaknesses
Table 89. Sanofi Basic Information, Area Served and Competitors
Table 90. Sanofi Major Business
Table 91. Sanofi Chronic Pain Topical Analgesics Product and Services
Table 92. Sanofi Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Sanofi Recent Developments/Updates
Table 94. Sanofi Competitive Strengths & Weaknesses
Table 95. Boehringer Ingelheim Basic Information, Area Served and Competitors
Table 96. Boehringer Ingelheim Major Business
Table 97. Boehringer Ingelheim Chronic Pain Topical Analgesics Product and Services
Table 98. Boehringer Ingelheim Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Boehringer Ingelheim Recent Developments/Updates
Table 100. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 101. Zhejiang Jiuzhou Pharmaceutical Basic Information, Area Served and Competitors
Table 102. Zhejiang Jiuzhou Pharmaceutical Major Business
Table 103. Zhejiang Jiuzhou Pharmaceutical Chronic Pain Topical Analgesics Product and Services
Table 104. Zhejiang Jiuzhou Pharmaceutical Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Zhejiang Jiuzhou Pharmaceutical Recent Developments/Updates
Table 106. Zhejiang Jiuzhou Pharmaceutical Competitive Strengths & Weaknesses
Table 107. Hisamitsu Basic Information, Area Served and Competitors
Table 108. Hisamitsu Major Business
Table 109. Hisamitsu Chronic Pain Topical Analgesics Product and Services
Table 110. Hisamitsu Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Hisamitsu Recent Developments/Updates
Table 112. Hisamitsu Competitive Strengths & Weaknesses
Table 113. Mylan Basic Information, Area Served and Competitors
Table 114. Mylan Major Business
Table 115. Mylan Chronic Pain Topical Analgesics Product and Services
Table 116. Mylan Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Mylan Recent Developments/Updates
Table 118. Mylan Competitive Strengths & Weaknesses
Table 119. Lingrui Basic Information, Area Served and Competitors
Table 120. Lingrui Major Business
Table 121. Lingrui Chronic Pain Topical Analgesics Product and Services
Table 122. Lingrui Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Lingrui Recent Developments/Updates
Table 124. Lingrui Competitive Strengths & Weaknesses
Table 125. Teikoku Seiyaku Basic Information, Area Served and Competitors
Table 126. Teikoku Seiyaku Major Business
Table 127. Teikoku Seiyaku Chronic Pain Topical Analgesics Product and Services
Table 128. Teikoku Seiyaku Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Teikoku Seiyaku Recent Developments/Updates
Table 130. Teikoku Seiyaku Competitive Strengths & Weaknesses
Table 131. The Pure Source Basic Information, Area Served and Competitors
Table 132. The Pure Source Major Business
Table 133. The Pure Source Chronic Pain Topical Analgesics Product and Services
Table 134. The Pure Source Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. The Pure Source Recent Developments/Updates
Table 136. Mercury Healthcare Basic Information, Area Served and Competitors
Table 137. Mercury Healthcare Major Business
Table 138. Mercury Healthcare Chronic Pain Topical Analgesics Product and Services
Table 139. Mercury Healthcare Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 140. Global Key Players of Chronic Pain Topical Analgesics Upstream (Raw Materials)
Table 141. Chronic Pain Topical Analgesics Typical Customers
List of Figure
Figure 1. Chronic Pain Topical Analgesics Picture
Figure 2. World Chronic Pain Topical Analgesics Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Chronic Pain Topical Analgesics Total Market Size (2018-2029) & (USD Million)
Figure 4. World Chronic Pain Topical Analgesics Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Chronic Pain Topical Analgesics Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Chronic Pain Topical Analgesics Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Chronic Pain Topical Analgesics Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Chronic Pain Topical Analgesics Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Chronic Pain Topical Analgesics Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Chronic Pain Topical Analgesics Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Chronic Pain Topical Analgesics Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Chronic Pain Topical Analgesics Revenue (2018-2029) & (USD Million)
Figure 13. Chronic Pain Topical Analgesics Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Chronic Pain Topical Analgesics Consumption Value (2018-2029) & (USD Million)
Figure 16. World Chronic Pain Topical Analgesics Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Chronic Pain Topical Analgesics Consumption Value (2018-2029) & (USD Million)
Figure 18. China Chronic Pain Topical Analgesics Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Chronic Pain Topical Analgesics Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Chronic Pain Topical Analgesics Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Chronic Pain Topical Analgesics Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Chronic Pain Topical Analgesics Consumption Value (2018-2029) & (USD Million)
Figure 23. India Chronic Pain Topical Analgesics Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Chronic Pain Topical Analgesics by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Chronic Pain Topical Analgesics Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Chronic Pain Topical Analgesics Markets in 2022
Figure 27. United States VS China: Chronic Pain Topical Analgesics Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Chronic Pain Topical Analgesics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Chronic Pain Topical Analgesics Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Chronic Pain Topical Analgesics Market Size Market Share by Type in 2022
Figure 31. Analgesic Creams
Figure 32. Analgesic Sprays
Figure 33. Pain Relief Patches
Figure 34. World Chronic Pain Topical Analgesics Market Size Market Share by Type (2018-2029)
Figure 35. World Chronic Pain Topical Analgesics Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Chronic Pain Topical Analgesics Market Size Market Share by Application in 2022
Figure 37. Muscle Pain
Figure 38. Arthritis Pain
Figure 39. Chronic Pain Topical Analgesics Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
Table 1. World Chronic Pain Topical Analgesics Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Chronic Pain Topical Analgesics Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Chronic Pain Topical Analgesics Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Chronic Pain Topical Analgesics Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Chronic Pain Topical Analgesics Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Chronic Pain Topical Analgesics Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Chronic Pain Topical Analgesics Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Chronic Pain Topical Analgesics Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Chronic Pain Topical Analgesics Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Chronic Pain Topical Analgesics Players in 2022
Table 12. World Chronic Pain Topical Analgesics Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Chronic Pain Topical Analgesics Company Evaluation Quadrant
Table 14. Head Office of Key Chronic Pain Topical Analgesics Player
Table 15. Chronic Pain Topical Analgesics Market: Company Product Type Footprint
Table 16. Chronic Pain Topical Analgesics Market: Company Product Application Footprint
Table 17. Chronic Pain Topical Analgesics Mergers & Acquisitions Activity
Table 18. United States VS China Chronic Pain Topical Analgesics Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Chronic Pain Topical Analgesics Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Chronic Pain Topical Analgesics Companies, Headquarters (States, Country)
Table 21. United States Based Companies Chronic Pain Topical Analgesics Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Chronic Pain Topical Analgesics Revenue Market Share (2018-2023)
Table 23. China Based Chronic Pain Topical Analgesics Companies, Headquarters (Province, Country)
Table 24. China Based Companies Chronic Pain Topical Analgesics Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Chronic Pain Topical Analgesics Revenue Market Share (2018-2023)
Table 26. Rest of World Based Chronic Pain Topical Analgesics Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Chronic Pain Topical Analgesics Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Chronic Pain Topical Analgesics Revenue Market Share (2018-2023)
Table 29. World Chronic Pain Topical Analgesics Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Chronic Pain Topical Analgesics Market Size by Type (2018-2023) & (USD Million)
Table 31. World Chronic Pain Topical Analgesics Market Size by Type (2024-2029) & (USD Million)
Table 32. World Chronic Pain Topical Analgesics Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Chronic Pain Topical Analgesics Market Size by Application (2018-2023) & (USD Million)
Table 34. World Chronic Pain Topical Analgesics Market Size by Application (2024-2029) & (USD Million)
Table 35. Roche (Genentech) Basic Information, Area Served and Competitors
Table 36. Roche (Genentech) Major Business
Table 37. Roche (Genentech) Chronic Pain Topical Analgesics Product and Services
Table 38. Roche (Genentech) Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Roche (Genentech) Recent Developments/Updates
Table 40. Roche (Genentech) Competitive Strengths & Weaknesses
Table 41. Amgen Basic Information, Area Served and Competitors
Table 42. Amgen Major Business
Table 43. Amgen Chronic Pain Topical Analgesics Product and Services
Table 44. Amgen Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Amgen Recent Developments/Updates
Table 46. Amgen Competitive Strengths & Weaknesses
Table 47. B-MS Basic Information, Area Served and Competitors
Table 48. B-MS Major Business
Table 49. B-MS Chronic Pain Topical Analgesics Product and Services
Table 50. B-MS Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. B-MS Recent Developments/Updates
Table 52. B-MS Competitive Strengths & Weaknesses
Table 53. Merck Basic Information, Area Served and Competitors
Table 54. Merck Major Business
Table 55. Merck Chronic Pain Topical Analgesics Product and Services
Table 56. Merck Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Merck Recent Developments/Updates
Table 58. Merck Competitive Strengths & Weaknesses
Table 59. Pfizer Basic Information, Area Served and Competitors
Table 60. Pfizer Major Business
Table 61. Pfizer Chronic Pain Topical Analgesics Product and Services
Table 62. Pfizer Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Pfizer Recent Developments/Updates
Table 64. Pfizer Competitive Strengths & Weaknesses
Table 65. Novartis Basic Information, Area Served and Competitors
Table 66. Novartis Major Business
Table 67. Novartis Chronic Pain Topical Analgesics Product and Services
Table 68. Novartis Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Novartis Recent Developments/Updates
Table 70. Novartis Competitive Strengths & Weaknesses
Table 71. Eli Lilly and Company Basic Information, Area Served and Competitors
Table 72. Eli Lilly and Company Major Business
Table 73. Eli Lilly and Company Chronic Pain Topical Analgesics Product and Services
Table 74. Eli Lilly and Company Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Eli Lilly and Company Recent Developments/Updates
Table 76. Eli Lilly and Company Competitive Strengths & Weaknesses
Table 77. Johnson & Johnson Basic Information, Area Served and Competitors
Table 78. Johnson & Johnson Major Business
Table 79. Johnson & Johnson Chronic Pain Topical Analgesics Product and Services
Table 80. Johnson & Johnson Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Johnson & Johnson Recent Developments/Updates
Table 82. Johnson & Johnson Competitive Strengths & Weaknesses
Table 83. GSK Basic Information, Area Served and Competitors
Table 84. GSK Major Business
Table 85. GSK Chronic Pain Topical Analgesics Product and Services
Table 86. GSK Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. GSK Recent Developments/Updates
Table 88. GSK Competitive Strengths & Weaknesses
Table 89. Sanofi Basic Information, Area Served and Competitors
Table 90. Sanofi Major Business
Table 91. Sanofi Chronic Pain Topical Analgesics Product and Services
Table 92. Sanofi Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Sanofi Recent Developments/Updates
Table 94. Sanofi Competitive Strengths & Weaknesses
Table 95. Boehringer Ingelheim Basic Information, Area Served and Competitors
Table 96. Boehringer Ingelheim Major Business
Table 97. Boehringer Ingelheim Chronic Pain Topical Analgesics Product and Services
Table 98. Boehringer Ingelheim Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Boehringer Ingelheim Recent Developments/Updates
Table 100. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 101. Zhejiang Jiuzhou Pharmaceutical Basic Information, Area Served and Competitors
Table 102. Zhejiang Jiuzhou Pharmaceutical Major Business
Table 103. Zhejiang Jiuzhou Pharmaceutical Chronic Pain Topical Analgesics Product and Services
Table 104. Zhejiang Jiuzhou Pharmaceutical Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Zhejiang Jiuzhou Pharmaceutical Recent Developments/Updates
Table 106. Zhejiang Jiuzhou Pharmaceutical Competitive Strengths & Weaknesses
Table 107. Hisamitsu Basic Information, Area Served and Competitors
Table 108. Hisamitsu Major Business
Table 109. Hisamitsu Chronic Pain Topical Analgesics Product and Services
Table 110. Hisamitsu Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Hisamitsu Recent Developments/Updates
Table 112. Hisamitsu Competitive Strengths & Weaknesses
Table 113. Mylan Basic Information, Area Served and Competitors
Table 114. Mylan Major Business
Table 115. Mylan Chronic Pain Topical Analgesics Product and Services
Table 116. Mylan Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Mylan Recent Developments/Updates
Table 118. Mylan Competitive Strengths & Weaknesses
Table 119. Lingrui Basic Information, Area Served and Competitors
Table 120. Lingrui Major Business
Table 121. Lingrui Chronic Pain Topical Analgesics Product and Services
Table 122. Lingrui Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Lingrui Recent Developments/Updates
Table 124. Lingrui Competitive Strengths & Weaknesses
Table 125. Teikoku Seiyaku Basic Information, Area Served and Competitors
Table 126. Teikoku Seiyaku Major Business
Table 127. Teikoku Seiyaku Chronic Pain Topical Analgesics Product and Services
Table 128. Teikoku Seiyaku Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Teikoku Seiyaku Recent Developments/Updates
Table 130. Teikoku Seiyaku Competitive Strengths & Weaknesses
Table 131. The Pure Source Basic Information, Area Served and Competitors
Table 132. The Pure Source Major Business
Table 133. The Pure Source Chronic Pain Topical Analgesics Product and Services
Table 134. The Pure Source Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. The Pure Source Recent Developments/Updates
Table 136. Mercury Healthcare Basic Information, Area Served and Competitors
Table 137. Mercury Healthcare Major Business
Table 138. Mercury Healthcare Chronic Pain Topical Analgesics Product and Services
Table 139. Mercury Healthcare Chronic Pain Topical Analgesics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 140. Global Key Players of Chronic Pain Topical Analgesics Upstream (Raw Materials)
Table 141. Chronic Pain Topical Analgesics Typical Customers
List of Figure
Figure 1. Chronic Pain Topical Analgesics Picture
Figure 2. World Chronic Pain Topical Analgesics Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Chronic Pain Topical Analgesics Total Market Size (2018-2029) & (USD Million)
Figure 4. World Chronic Pain Topical Analgesics Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Chronic Pain Topical Analgesics Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Chronic Pain Topical Analgesics Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Chronic Pain Topical Analgesics Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Chronic Pain Topical Analgesics Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Chronic Pain Topical Analgesics Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Chronic Pain Topical Analgesics Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Chronic Pain Topical Analgesics Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Chronic Pain Topical Analgesics Revenue (2018-2029) & (USD Million)
Figure 13. Chronic Pain Topical Analgesics Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Chronic Pain Topical Analgesics Consumption Value (2018-2029) & (USD Million)
Figure 16. World Chronic Pain Topical Analgesics Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Chronic Pain Topical Analgesics Consumption Value (2018-2029) & (USD Million)
Figure 18. China Chronic Pain Topical Analgesics Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Chronic Pain Topical Analgesics Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Chronic Pain Topical Analgesics Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Chronic Pain Topical Analgesics Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Chronic Pain Topical Analgesics Consumption Value (2018-2029) & (USD Million)
Figure 23. India Chronic Pain Topical Analgesics Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Chronic Pain Topical Analgesics by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Chronic Pain Topical Analgesics Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Chronic Pain Topical Analgesics Markets in 2022
Figure 27. United States VS China: Chronic Pain Topical Analgesics Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Chronic Pain Topical Analgesics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Chronic Pain Topical Analgesics Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Chronic Pain Topical Analgesics Market Size Market Share by Type in 2022
Figure 31. Analgesic Creams
Figure 32. Analgesic Sprays
Figure 33. Pain Relief Patches
Figure 34. World Chronic Pain Topical Analgesics Market Size Market Share by Type (2018-2029)
Figure 35. World Chronic Pain Topical Analgesics Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Chronic Pain Topical Analgesics Market Size Market Share by Application in 2022
Figure 37. Muscle Pain
Figure 38. Arthritis Pain
Figure 39. Chronic Pain Topical Analgesics Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
